APIs

APIs refers to active pharmaceutical ingredients, the core chemical or biologic substances used to make medicines. Companies in this category are typically exposed to manufacturing scale, supply reliability, and the economics of pharmaceutical production rather than a single branded asset story.

Why watch APIs

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest APIs news

The latest feed items from companies currently grouped under APIs.

1. 01
   2026-09-11 18:00 EST

   PHARFDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.

   Source: Pharming Group

2. 02
   2026-09-09 06:00 EST

   PHARPharming Group to participate in September investor conferences

   Source: Pharming Group

3. 03
   2026-08-13 05:00 EST

   PHARPharming announces commercial launch of Joenja (leniolisib) in Japan for adult and pediatric patients with APDS aged 4 and older

   Source: Pharming Group

4. 04
   2026-08-04 06:00 EST

   PHARPharming Group to participate in Canaccord Genuity 46th Annual Growth Conference

   Source: Pharming Group

5. 05
   2026-07-30 05:00 EST

   PHARPharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use

   Source: Pharming Group

6. 06
   2026-07-16 06:00 EST

   PHARPharming Group to report second quarter and first half 2026 financial results and provide business update on July 30

   Source: Pharming Group

7. 07
   2026-06-04 05:00 EST

   PHARPharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

   Source: Pharming Group

8. 08
   2026-06-02 06:00 EST

   PHARPharming Group to participate in Fireside Chat at 2026 Jefferies Global Healthcare Conference in New York

   Source: Pharming Group

9. 09
   2026-05-28 14:40 EST

   PHARPharming Group announces results of 2026 Annual General Meeting of Shareholders

   Source: Pharming Group

10. 10
    2026-05-22 19:30 EST

    PHAREuropean Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

    Source: Pharming Group

11. 11
    2026-05-07 05:05 EST

    PHARPharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders

    Source: Pharming Group

12. 12
    2026-05-07 05:00 EST

    PHARPharming Group reports first quarter 2026 financial results; on track for Joenja® U.S. pediatric label expansion and launches in Japan and Europe in 2026

    Source: Pharming Group

13. 13
    2026-04-23 06:00 EST

    PHARPharming Group to report first quarter 2026 financial results and provide business update on May 7

    Source: Pharming Group

14. 14
    2026-04-16 06:00 EST

    PHARPharming Group announces the 2026 Annual General Meeting of Shareholders

    Source: Pharming Group

15. 15
    2026-04-07 06:00 EST

    PHARPharming Group to participate in April investor conferences

    Source: Pharming Group

16. 16
    2026-04-02 05:00 EST

    PHARPharming Group announces the filing of its 2025 Annual Report and Form 20-F

    Source: Pharming Group

17. 17
    2026-03-27 06:00 EST

    PHARPharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older

    Source: Pharming Group

18. 18
    2026-03-24 06:00 EST

    PHARPharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older

    Source: Pharming Group

19. 19
    2026-03-12 06:00 EST

    PHARPharming Group reports fourth quarter and full year 2025 financial results, delivering strong revenue growth and profitability with positive cash flow

    Source: Pharming Group

20. 20
    2026-02-26 07:00 EST

    PHARPharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12

    Source: Pharming Group

Companies in APIs

3 companies tagged with APIs.

Frequently Asked Questions